Dario A. Paggiarino - Mar 30, 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Chief Medical Officer
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Mar 30, 2024
Transactions value $
-$528,036
Form type
4
Date filed
4/2/2024, 05:27 PM
Previous filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +5.83K +13.82% $0.00 48.1K Mar 30, 2024 Direct
transaction EYPT Common Stock Options Exercise $0 +30.6K +63.61% $0.00 78.6K Mar 30, 2024 Direct
transaction EYPT Common Stock Options Exercise $0 +14K +17.81% $0.00 92.6K Mar 30, 2024 Direct
transaction EYPT Common Stock Tax liability -$320K -15.5K -16.73% $20.67 77.1K Mar 30, 2024 Direct F1
transaction EYPT Common Stock Tax liability -$61.1K -2.96K -3.83% $20.67 74.2K Mar 30, 2024 Direct F1
transaction EYPT Common Stock Tax liability -$147K -7.1K -9.57% $20.67 67.1K Mar 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -30.6K -100% $0.00* 0 Mar 30, 2024 Common Stock 30.6K $0.00 Direct F2
transaction EYPT Restricted Stock Units Options Exercise $0 -5.83K -100% $0.00* 0 Mar 30, 2024 Common Stock 5.83K $0.00 Direct F3
transaction EYPT Restricted Stock Units Options Exercise $0 -14K -100% $0.00* 0 Mar 30, 2024 Common Stock 14K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dario A. Paggiarino is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F2 The restricted stock units will vest in three ratable annual installments beginning January 6, 2024.
F3 The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
F4 The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.